SELLAS Life Sciences Group, Inc.SLSNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank36
3Y CAGR-19.1%
5Y CAGR+11.5%
Year-over-Year Change
Research and development spending
3Y CAGR
-19.1%/yr
vs +13.4%/yr prior
5Y CAGR
+11.5%/yr
Recent deceleration
Acceleration
-32.5pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $16.02M | -16.1% |
| 2024 | $19.10M | -20.5% |
| 2023 | $24.01M | -20.7% |
| 2022 | $30.27M | +41.6% |
| 2021 | $21.37M | +130.3% |
| 2020 | $9.28M | -8.3% |
| 2019 | $10.12M | -44.8% |
| 2018 | $18.32M | +201.9% |
| 2017 | $6.07M | -69.5% |
| 2016 | $19.86M | - |